Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Bennett, Charles
Item TypeName
Academic Article Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.
Academic Article Editorial comment.
Academic Article Finishing the picture: problems with public reporting of clinical trials.
Concept Antineoplastic Agents
Concept Antineoplastic Agents, Hormonal
Academic Article Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents.
Academic Article Reply to W. Read.
Academic Article Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer.
Academic Article Toxicity and costs of toxicity associated with new cancer drugs: international implications.
Academic Article Regulatory and clinical considerations for biosimilar oncology drugs.
Academic Article Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials.
Academic Article The effect of reimbursement policies on the management of Medicare patients with refractory ovarian cancer.
Academic Article Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?
Academic Article Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs.
Academic Article Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists.
Academic Article Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.
Academic Article Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancer.
Academic Article Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
Academic Article A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.
Academic Article American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.
Academic Article Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.
Academic Article Reducing adverse drug events in the outpatient chemotherapy setting: attention must be paid.
Academic Article Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs.
Academic Article When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective?
Academic Article Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.
Academic Article Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project.
Academic Article Myeloid growth factors. Clinical practice guidelines in oncology.
Academic Article Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.
Academic Article Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports project.
Academic Article Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.
Academic Article Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.
Academic Article Dermatologic challenges in cancer patients and survivors.
Academic Article Cancer- and chemotherapy-induced anemia.
Academic Article Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
Academic Article Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.
Academic Article Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer.
Academic Article Myeloid growth factors.
Academic Article Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.
Academic Article Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?
Academic Article Reassessments of ESAs for cancer treatment in the US and Europe.
Academic Article Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer.
Academic Article Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.
Academic Article Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR).
Academic Article Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone.
Academic Article The utility of prostate-specific antigen in the management of advanced prostate cancer.
Academic Article Geography: an increasingly important variable in prostate cancer clinical trials.
Academic Article Japanese regulatory authority's perspective on biosimilars - authors' reply.
Academic Article Screening for viral hepatitis prior to rituximab chemotherapy.
Academic Article Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells.
Academic Article Associations Between Industry Sponsorship and Results of Cost-effectiveness Analyses of Drugs Used in Breast Cancer Treatment.
Academic Article Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry.
Academic Article Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system.
Academic Article Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.
Academic Article Generic oncology drugs: are they all safe?
Academic Article Interpretation of surrogate endpoints in the era of the 21st Century Cures Act.
Academic Article Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA.
Academic Article Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia.
Academic Article Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
Academic Article Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre-ibrutinib era: Incidence and risk factors.
Academic Article Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.
Academic Article End of an era for erythropoiesis-stimulating agents in oncology.
Academic Article Pharmacoeconomics of amifostine in ovarian cancer.
Academic Article Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients.
Academic Article Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials.
Academic Article Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma.
Academic Article Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.
Academic Article Maximal androgen blockade for advanced prostate cancer.
Academic Article Comparative study of the clinical efficacy of two dosing regimens of flutamide.
Academic Article Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.
Academic Article Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany.
Academic Article Cost-effectiveness considerations in the treatment of essential thrombocythemia.
Academic Article Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma.
Academic Article The First 2?Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
Academic Article Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
Academic Article End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
Concept Antineoplastic Agents, Immunological
Academic Article Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series.
Academic Article Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions.
Academic Article Single-arm clinical trials that supported FDA accelerated approvals have modest effect sizes and were at high risk of bias.
Search Criteria
  • Antineoplastic Agents